Health••10 sources checked

Characteristics of Gastric Mucosa-Associated Microbiota in Patients with Early Gastric Cancer After Successful Helicobacter pylori Eradication.

True
Our verdict

This claim is supported by the available evidence.

trusted sources

Analysis

Multiple peer-reviewed studies and reviews report that researchers have characterized the gastric mucosa–associated microbiota in patients with early gastric cancer (EGC) after successful Helicobacter pylori eradication, and have described consistent patterns such as altered diversity and shifts in bacterial composition compared with H. pylori–positive or uninfected stomachs. Several reports note partial restoration of microbial diversity after eradication but persistence of dysbiotic features in some patients, and identify enrichment of non-Helicobacter taxa (e.g., Clostridium, Fusobacterium and other oral/gut-associated genera) in EGC cases. While methods, cohorts and sampling sites differ between studies—leading to heterogeneity in specific taxa reported—the overall body of literature supports the claim that the gastric mucosal microbiota in post‑eradication EGC patients has distinct, characterizable features that have been described in multiple publications.

Sources (10)

  1. The Gut review explicitly states that H. pylori eradication partially restores microbial diversity in patients with early gastric cancer and summarizes compositional changes observed in such cohorts.

  2. The NIH/PMC review discusses interactions between H. pylori and the gastric microbiome and cites studies of microbiota after endoscopic treatment for early gastric cancer, supporting characterization efforts.

  3. This PubMed-indexed review documents gastric microbiota alterations in gastric cancer generally and discusses H. pylori’s role, but does not focus exclusively on post‑eradication EGC mucosal microbiota.

  4. The review on gastric microbiota beyond H. pylori outlines the importance of non‑Helicobacter taxa in gastric cancer and cites studies that characterize post‑eradication communities, but is broader in scope.

  5. The cited article about core gastric microbiota and pathogenesis discusses H. pylori’s role and microbiota shifts relevant to gastric cancer, lending indirect support though not necessarily focused solely on post‑eradication EGC.

  6. The Springer Nature chapter on the gastric microbiome highlights insights into early gastric cancer and microbiota changes after eradication, but reads as a broader synthesis rather than an original focused study.

  7. The Frontiers piece reports significant perturbations of diversity after H. pylori eradication and references EGC contexts, supporting the claim though study specifics may vary.

  8. This 2019 study specifically examines relative abundance of gastric microbiota in early gastric cancer patients and discusses bacterial succession after H. pylori loss, directly supporting characterization in such patients.

  9. The 2017 molecular characterization paper establishes baseline knowledge of stomach microbiota including H. pylori’s dominance and other taxa, supporting the feasibility and occurrence of such characterizations but not limited to post‑eradication EGC.

  10. The 2018 report noting increased Clostridium and Fusobacterium in gastric cancer supports specific taxa observed in EGC and post‑eradication contexts, though it is not solely an analysis of mucosa after successful eradication.

How this fact check was made

How this fact check was made. This claim was submitted by a user of the AI Fact Checker app on October 2, 2026. Our AI compared coverage from 10 sources, weighted trusted outlets more heavily and summarised the evidence. AI can make mistakes, so always review the sources above, especially for fast-moving news.